Treatment Strategies
From Antihistamines to Desensitisation

Antihistamines remain the most commonly prescribed treatment for allergic reactions to mould and other airborne allergens. These medications work by blocking histamine receptors, preventing the chemical cascade that causes sneezing, itchy eyes, runny nose, and skin irritation.

Modern second-generation antihistamines such as cetirizine, loratadine, and fexofenadine offer effective symptom control without the drowsiness associated with older formulations. They are suitable for daily use and can significantly improve comfort during high mould exposure periods.

While antihistamines provide valuable symptom relief, they do not address the underlying allergy or reduce sensitivity over time. They are best used as part of a broader treatment strategy that includes environmental controls and potential immunotherapy.

• Non-drowsy formulations available for daytime use during work or study
• Most effective when taken regularly during allergy season rather than only when symptoms appear
• Generally well-tolerated with minimal side effects in healthy adults
• Available over-the-counter for convenient access

For individuals experiencing significant nasal congestion, post-nasal drip, or sinus pressure due to mould exposure, nasal corticosteroid sprays offer targeted relief. These medications reduce inflammation directly in the nasal passages where mould spores first make contact with respiratory tissues.

Prescription and over-the-counter options include fluticasone, mometasone, and budesonide. Unlike oral medications, nasal sprays deliver treatment directly to affected tissues with minimal systemic absorption, making them suitable for long-term use under medical supervision.

Maximum effectiveness typically requires consistent use for 1-2 weeks, so they are most beneficial when started before expected high-exposure periods or used continuously during the humid summer months in Sydney when indoor mould growth peaks.

Allergic conjunctivitis triggered by mould spores can cause intense itching, redness, and watering of the eyes. Antihistamine eye drops provide fast-acting, targeted relief by blocking histamine receptors in the conjunctival tissues.

Over-the-counter options containing ketotifen or prescription formulations with olopatadine or azelastine can be used multiple times daily during acute symptoms. For chronic symptoms, mast cell stabilizer drops offer preventive benefits when used regularly.

Topical treatments for skin reactions, including hydrocortisone creams for mild rashes or prescription corticosteroid ointments for more severe dermatitis, can manage contact reactions when mould contamination affects skin directly.

Allergen immunotherapy represents the only treatment strategy that can fundamentally alter immune response and potentially cure allergic reactions to mould. This approach involves gradual exposure to increasing doses of specific allergens, retraining the immune system to tolerate substances that previously triggered reactions.

Two primary forms of immunotherapy are available in Australia: subcutaneous immunotherapy (allergy shots administered by injection) and sublingual immunotherapy (tablets or drops placed under the tongue). Both require commitment to treatment schedules spanning 3-5 years for maximum benefit.

Clinical studies demonstrate that successful immunotherapy can reduce symptoms by 70-80% and significantly decrease reliance on daily medications. Benefits often persist for years after treatment completion, making this the preferred option for individuals with severe, persistent mould allergies.

• Requires accurate allergy testing to identify specific mould species triggering reactions
• Treatment protocols are customised to individual allergen profiles
• Regular medical monitoring ensures safe dose escalation
• Most effective when started during low-exposure seasons
• Can reduce risk of developing new allergies over time

Most allergists recommend combination approaches that layer multiple treatment modalities for optimal symptom control and long-term immune modification. A typical protocol might include daily antihistamines for baseline symptom prevention, nasal corticosteroids during high-exposure periods, and immunotherapy for gradual desensitisation.

This layered strategy addresses both immediate symptom relief and long-term reduction in allergy severity. Patients often find they can gradually reduce medication reliance as immunotherapy progresses and environmental controls take effect.

Treatment plans should be reviewed regularly with healthcare providers, adjusting medication dosages and combinations based on symptom patterns, exposure levels, and treatment response over time.

Even the most effective medication regimen cannot fully compensate for continuous high-level mould exposure. Professional mould remediation addresses the root cause of allergic reactions by eliminating active colonies and preventing regrowth through barrier treatments and moisture control.

Nanotise specialises in comprehensive mould removal protocols that combine immediate colony elimination with long-term prevention strategies. Our hospital-grade treatments are TGA-registered and safe for homes with allergy sufferers, removing the source of airborne spores that trigger symptoms.

Following professional remediation, maintaining indoor humidity below 55%, ensuring adequate ventilation, and promptly addressing water leaks creates an environment where treatment medications and immunotherapy can achieve maximum effectiveness without constant re-exposure to allergens.

• Air purifiers with HEPA filters capture airborne mould spores before inhalation
• Dehumidifiers maintain optimal humidity levels that prevent mould regrowth
• Regular inspection of high-risk areas identifies problems before colonies establish
• Professional barrier treatments like CRX nanotechnology provide lasting surface protection

While most mould allergies cause uncomfortable but manageable symptoms, certain reactions require immediate medical evaluation. Difficulty breathing, chest tightness, severe facial swelling, or dizziness following mould exposure may indicate anaphylaxis or acute respiratory distress requiring emergency treatment.

Individuals with asthma face heightened risk, as mould exposure can trigger severe bronchospasm and respiratory compromise. An emergency action plan developed with a respiratory specialist should outline medication protocols and thresholds for seeking urgent care.

Chronic symptoms that progressively worsen despite treatment, or new neurological symptoms such as severe headaches, memory difficulties, or balance problems, warrant comprehensive medical evaluation to rule out more serious conditions including chronic inflammatory response syndrome (CIRS).

Effective allergy management begins with accurate diagnosis through skin prick testing or blood tests that identify specific mould species triggering reactions. Results guide treatment selection, as immunotherapy protocols must target the actual allergens present in the home environment.

Working with an allergist or immunologist, patients develop treatment plans that balance symptom control, medication side effects, treatment costs, and lifestyle factors. Plans should include medication schedules, immunotherapy timelines if appropriate, environmental modification strategies, and trigger avoidance techniques.

Regular follow-up appointments allow providers to assess treatment effectiveness, adjust medication dosages, monitor immunotherapy progress, and refine environmental control recommendations based on symptom patterns throughout the year.